Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125585521 | 12558552 | 1 | I | 20160424 | 20160701 | 20160714 | 20160714 | EXP | FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-055278 | BRISTOL MYERS SQUIBB | 93.63 | YR | F | Y | 0.00000 | 20160714 | CN | FR | FR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125585521 | 12558552 | 1 | PS | COUMADINE | WARFARIN SODIUM | 1 | Oral | 2 MG, QD | U | 9218 | 2 | MG | TABLET | QD | |||||
125585521 | 12558552 | 2 | SS | LOVENOX | ENOXAPARIN SODIUM | 1 | Subcutaneous | 0.8 ML, QD | U | 0 | .8 | ML | QD | ||||||
125585521 | 12558552 | 3 | C | TARDYFERON | FERROUS SULFATE | 1 | Unknown | 160 MG, QD | U | 0 | 160 | MG | QD | ||||||
125585521 | 12558552 | 4 | C | DAFALGAN | ACETAMINOPHEN | 1 | Unknown | 3 G, QD | U | 0 | 3 | G | QD | ||||||
125585521 | 12558552 | 5 | C | AMIODARONE /00133102/ | AMIODARONE | 1 | Unknown | 200 MG, QD | U | 0 | 200 | MG | QD | ||||||
125585521 | 12558552 | 6 | C | DIFFU-K | POTASSIUM CHLORIDE | 1 | Unknown | 200 MG, QD | U | 0 | 200 | MG | QD | ||||||
125585521 | 12558552 | 7 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Unknown | 20 MG, QD | U | 0 | 20 | MG | QD | ||||||
125585521 | 12558552 | 8 | C | SPASFON /00765801/ | PHLOROGLUCINOL1,3,5-TRIMETHOXYBENZENE | 1 | Unknown | 240 MG, QD | U | 0 | 240 | MG | QD | ||||||
125585521 | 12558552 | 9 | C | STRESAM | ETIFOXINE | 1 | Unknown | UNK UNK, QD | U | 0 | CAPSULE | QD | |||||||
125585521 | 12558552 | 10 | C | ZOPICLONE | ZOPICLONE | 1 | Unknown | 7.5 MG, QD | U | 0 | 7.5 | MG | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125585521 | 12558552 | 1 | Atrial fibrillation |
125585521 | 12558552 | 2 | Product used for unknown indication |
125585521 | 12558552 | 3 | Product used for unknown indication |
125585521 | 12558552 | 4 | Product used for unknown indication |
125585521 | 12558552 | 5 | Product used for unknown indication |
125585521 | 12558552 | 6 | Product used for unknown indication |
125585521 | 12558552 | 7 | Product used for unknown indication |
125585521 | 12558552 | 8 | Abdominal pain |
125585521 | 12558552 | 9 | Stress |
125585521 | 12558552 | 10 | Stress |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125585521 | 12558552 | HO |
125585521 | 12558552 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125585521 | 12558552 | Aggression | |
125585521 | 12558552 | Anaemia | |
125585521 | 12558552 | Cyanosis | |
125585521 | 12558552 | Fall | |
125585521 | 12558552 | Femoral neck fracture | |
125585521 | 12558552 | Hypotension | |
125585521 | 12558552 | Hypoxia | |
125585521 | 12558552 | Melaena | |
125585521 | 12558552 | Osteoporosis | |
125585521 | 12558552 | Pallor | |
125585521 | 12558552 | Restlessness |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125585521 | 12558552 | 1 | 20160504 | 0 | ||
125585521 | 12558552 | 2 | 20160504 | 0 | ||
125585521 | 12558552 | 3 | 20160504 | 0 | ||
125585521 | 12558552 | 4 | 20160504 | 0 | ||
125585521 | 12558552 | 7 | 20160318 | 0 |